Phase 1 is believed to correspond to the high level of activity in the primary afferent as by C-fiber activation due to peripheral stimulation, 9 whereas phase 2 seems to result from the continuous low level of small afferent input, together with a facilitated state of spinal processing
Injecting the wrong site for the goal
These may signal conditions unrelated to hormonal changes, such as thyroid, gallbladder, or gastrointestinal disorders
Rarely, allergic reactions can occur, requiring immediate medical attention if symptoms persist
LeuSynergy (Metabolic Flexibility) Supports muscle, improves fat metabolism, and helps the body adapt to calorie restriction
Systemic injection into abdominal fat also provides benefits, though potentially less concentrated at the specific injury site